Verastem Oncology
Healthcare & Life Sci
Company overview
Verastem Oncology is an American pharmaceutical company that develops cancer medicines, with a focus on drugs that target cancer stem cells. Its approved drug, duvelisib, sold as COPIKTRA, treats certain blood cancers such as chronic lymphocytic leukemia and received FDA approval in September 2018. The company is based in Needham, Massachusetts.
Verastem Oncology was founded in 2010 by entrepreneur Christoph Westphal and MIT biologists Robert Weinberg, Eric Lander, and Piyush Gupta. It went public in 2012, raising $55 million, and today employs between 100 and 200 people. Verastem Oncology is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Needham, United States